Japan Vows Anew To Overcome Reluctance To Boost Generics Use
This article was originally published in PharmAsia News
Executive Summary
Despite slow adoption, the potential for massive shift in Japan’s branded-generics market is a draw for foreign firms as policymakers see increased usage as key to containing health costs.